Non-EB RX Thread: Miller Buckfire v. Ducera v. GLC v. TRS v Gordian

Can anyone speak on the merits of these shops with regards to each other? Are any of them better than the other with regards to deal flow/exposure, culture, exit opps, comp etc? How strong are they in the RX world?

WSO Elite Modeling Package

  • 6 courses to mastery: Excel, Financial Statement, LBO, M&A, Valuation and DCF
  • Elite instructors from top BB investment banks and private equity megafunds
  • Includes Company DB + Video Library Access (1 year)

Comments (29)

  • Intern in PE - Other
Oct 28, 2021 - 3:07pm

Ducera is quite strong, preference for creditor work ex. Neiman Marcus, also do M&A from time to time although work environment might not be for everyone. Have heard anecdotally that pay is quite good. In some ways, based just on employees/scale and deals they have recently done, might be best of the group OP listed but I'll leave that up to others to decide. 

Learn More

300+ video lessons across 6 modeling courses taught by elite practitioners at the top investment banks and private equity funds -- Excel Modeling -- Financial Statement Modeling -- M&A Modeling -- LBO Modeling -- DCF and Valuation Modeling -- ALL INCLUDED + 2 Huge Bonuses.

Learn more
  • Analyst 2 in IB-M&A
Nov 1, 2021 - 5:54pm

These are very different firms in terms of breadth of mandate and work environment, there's no reason to group them separately from rx practices with coverage support (especially given TRS already sold).

Nov 1, 2021 - 6:26pm

What do you mean? It was my understanding that all of these firms are primarily RX first and their other functions are secondary.

Can you elaborate on the specifics of their differences in mandate and work environment?

  • Intern in IB - Gen
Nov 1, 2021 - 8:15pm

Gordian isn't the same tier as the rest of these. Ducera does some cool creditor work and TRS does too.

  • Intern in IB - Gen
Nov 20, 2021 - 8:10pm

Miller Buckfire is nowhere near where it used to be. Really fell off shortly after the financial crisis and doesn't get most of the big deals anymore. I believe mostly creditor side but I can't remember exactly. Most of the top bankers left years ago and are now high up in other rx shops (EVR, GUGG, CVP, to name a few).

  • Intern in IB - Gen
Nov 21, 2021 - 1:27pm

LMFAO Gordian Group is nowhere near the rest of these, they have one MD who's semi-decent but that's about all they have going for them. TRS and Ducera are both solid shops that will allow you to exit decently or at the very least, lateral to a better bank.

  • Associate 1 in HF - Event
Nov 25, 2021 - 11:48pm

I'm an associate at a large distressed/special sits fund and Ducera is by far the best of these, it's not even close. I haven't even heard of the others other than Miller Buckfire and GLC

Nov 26, 2021 - 12:34pm

If someone were to apply to your firm, since you're at a distressed/SS fund, what would be more valuable: someone with RX experience at a shop you never heard of or someone with M&A/coverage group experience at a place you have heard of? Wondering to what extent name brand outweighs the relevancy/similarity of prior work experience to what your fund does. 

  • Associate 1 in HF - Event
Nov 26, 2021 - 1:27pm

Sed aperiam sint dolores. Qui laudantium explicabo ducimus earum corporis. Neque molestiae adipisci perferendis at occaecati delectus et. Ex ex impedit sint est doloremque error esse. Eum ab nihil exercitationem in id et.

Explicabo nihil quas qui beatae placeat. Sint non aspernatur omnis enim est eveniet. Temporibus ad sit repellendus expedita architecto et. Earum delectus non odit cumque aperiam adipisci alias. Sint fugit corrupti ipsum necessitatibus rerum.

Start Discussion

Total Avg Compensation

November 2021 Investment Banking

  • Director/MD (10) $853
  • Vice President (40) $360
  • Associates (236) $235
  • 2nd Year Analyst (144) $156
  • 3rd+ Year Analyst (34) $154
  • Intern/Summer Associate (107) $146
  • 1st Year Analyst (514) $136
  • Intern/Summer Analyst (394) $84